mesulergine has been researched along with Parkinson Disease in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 26 (92.86) | 18.7374 |
| 1990's | 1 (3.57) | 18.2507 |
| 2000's | 1 (3.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burton, K; Calne, DB | 1 |
| Bystritsky, A; Engel, J; Goldstein, M; Lieberman, A; Mino, S; Regev, I | 1 |
| Jellinger, K | 1 |
| Biesemeyer, H; Ludin, HP; Ringwald, E | 1 |
| Beckman, J; Burton, K; Calne, DB; Martin, WR | 1 |
| Rinne, UK | 2 |
| Jensen, I; Pakkenberg, H | 1 |
| Agid, Y; Bonnet, AM; Esteguy, M; Guimaraes, J; Lhermitte, F | 1 |
| Fischer, PA; Hubener, K; Schneider, E | 2 |
| Brotchie, JM; Fox, SH | 1 |
| Goldstein, M; Gopinathan, G; Lieberman, AN; Pasternack, P | 1 |
| Palacios, JM; Waeber, C | 1 |
| Goldstein, M; Gopinathan, G; Lieberman, AN; Neophytides, A | 1 |
| Churg, A; Fleetham, JA; McElvaney, NG; Wilcox, PG | 1 |
| Lang, AE | 1 |
| Dupont, E; Jakobsen, J; Mikkelsen, B | 1 |
| Lees, AJ; Stern, GM; Wright, A | 1 |
| Montastruc, JL; Rascol, A; Rascol, O; Senard, JM | 1 |
| Jankovic, J; Jansson, B; Orman, J | 1 |
| Pfeiffer, RF | 1 |
| Glaeske, C; Pfeiffer, RF; Wilken, K | 1 |
| Bratty, PJ; Burton, K; Calne, DB; Larsen, TA; Martin, WR; Robinson, RG; Schulzer, M | 1 |
| Gopinathan, G; Lieberman, AN; Neophytides, A | 1 |
| Hietanen, M; Huttunen, J; Teräväinen, H | 1 |
| Baas, H; Fischer, PA; Japp, G; Schneider, E | 2 |
3 review(s) available for mesulergine and Parkinson Disease
| Article | Year |
|---|---|
D-1 and D-2 agonists in Parkinson's disease.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Dopamine; Ergolines; Female; Humans; Male; Middle Aged; Parkinson Disease; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1987 |
Update on dopamine agonists in Parkinson's disease: "beyond bromocriptine".
Topics: Antiparkinson Agents; Bromocriptine; Dopamine; Ergolines; Humans; Parkinson Disease; Piperazines | 1987 |
The pharmacology of mesulergine.
Topics: Animals; Antiparkinson Agents; Ergolines; Humans; Parkinson Disease; Receptors, Dopamine | 1985 |
8 trial(s) available for mesulergine and Parkinson Disease
| Article | Year |
|---|---|
Adjuvant treatment of Parkinson's disease with dopamine agonists: open trial with bromocriptine and CU 32-085.
Topics: Aged; Bromocriptine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Receptors, Dopamine | 1982 |
Treatment of Parkinson's disease with the ergoline derivatives CQ 32-084 and CU 32-085.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Disability Evaluation; Ergolines; Female; Humans; Male; Middle Aged; Parkinson Disease; Pilot Projects | 1983 |
Mesulergine: a dopamine agonist with novel properties in Parkinson's disease.
Topics: Aged; Dopamine Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease | 1990 |
Mesulergine in early Parkinson's disease: a double blind controlled trial.
Topics: Aged; Antiparkinson Agents; Benserazide; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Random Allocation | 1986 |
Placebo-controlled study of mesulergine in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Clinical Trials as Topic; Ergolines; Female; Humans; Male; Middle Aged; Parkinson Disease; Placebos | 1985 |
Mesulergine (CU32-085) in the treatment of Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Clinical Trials as Topic; Double-Blind Method; Ergolines; Female; Humans; Male; Middle Aged; Parkinson Disease; Random Allocation | 1985 |
Parkinson's disease: a comparison of mesulergine and bromocriptine.
Topics: Adult; Aged; Bromocriptine; Clinical Trials as Topic; Ergolines; Female; Humans; Male; Middle Aged; Movement; Nervous System; Parkinson Disease | 1985 |
Mesulergine and bromocriptine in long-term treatment of advanced parkinsonism.
Topics: Adult; Aged; Blood Pressure; Bromocriptine; Drug Administration Schedule; Ergolines; Female; Heart Rate; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors | 1985 |
17 other study(ies) available for mesulergine and Parkinson Disease
| Article | Year |
|---|---|
Dopamine agonists and Parkinson's disease.
Topics: Antiparkinson Agents; Apomorphine; Brain; Bromocriptine; Ergolines; Ergot Alkaloids; Humans; Levodopa; Lisuride; Neurons; Parkinson Disease; Pergolide; Piribedil; Receptors, Dopamine | 1984 |
Therapeutic potentials of centrally acting dopamine and alpha 2-adrenoreceptor agonists.
Topics: Adrenergic alpha-Agonists; Animals; Dopamine; Ergolines; Haplorhini; Humans; Neurons; Norepinephrine; Parkinson Disease; Pergolide; Quinpirole; Rats | 1983 |
Therapeutic experience with the new dopamine agonist CU 32-085 in advanced Parkinson's disease.
Topics: Adult; Aged; Amantadine; Antiparkinson Agents; Bromocriptine; Carboxy-Lyases; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parasympatholytics; Parkinson Disease | 1983 |
Dopamine agonists in Parkinson's disease.
Topics: Bromocriptine; Dopamine; Drug Therapy, Combination; Ergolines; Ergot Alkaloids; Humans; Levodopa; Lisuride; Parkinson Disease; Pergolide; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1984 |
Dopamine agonists in the treatment of Parkinson's disease.
Topics: Blood Pressure; Bromocriptine; Disability Evaluation; Domperidone; Dopamine; Ergolines; Follow-Up Studies; Humans; Levodopa; Parkinson Disease; Pleural Effusion; Receptors, Neurotransmitter; Time Factors | 1983 |
Low-dose CU 32-085 (mesulergine) in previously untreated Parkinson's disease.
Topics: Ergolines; Female; Humans; Male; Middle Aged; Parkinson Disease | 1984 |
Treatment of Parkinson's disease with 8-alpha-amino-ergoline, CU 32-085.
Topics: Activities of Daily Living; Adult; Aged; Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Ergolines; Female; Humans; Hypotension, Orthostatic; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Psychomotor Performance; Receptors, Dopamine | 1983 |
Therapeutic results with a new ergoline derivate (8-alpha-amino-ergoline, CU 32-085) in parkinsonian patients.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1984 |
5-HT2C receptor binding is increased in the substantia nigra pars reticulata in Parkinson's disease.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Autoradiography; Binding Sites; Brain; Dopamine Agonists; Dyskinesia, Drug-Induced; Ergolines; Female; Humans; Male; Parkinson Disease; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Serotonin Antagonists; Substantia Nigra | 2000 |
Serotonin-1 receptor binding sites in the human basal ganglia are decreased in Huntington's chorea but not in Parkinson's disease: a quantitative in vitro autoradiography study.
Topics: Aged; Basal Ganglia; Ergolines; Female; Humans; Huntington Disease; Male; Middle Aged; Parkinson Disease; Receptors, Serotonin | 1989 |
Dopamine agonists as primary treatment in Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Disability Evaluation; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Lisuride; Long-Term Care; Parkinson Disease; Pergolide; Receptors, Dopamine | 1987 |
Pleuropulmonary disease during bromocriptine treatment of Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Ergolines; Humans; Lung Diseases; Male; Middle Aged; Parkinson Disease; Pleural Diseases; Radiography | 1988 |
Mesulergine and pergolide in previously untreated Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Domperidone; Ergolines; Female; Humans; Male; Parkinson Disease; Pergolide | 1987 |
Mesulergine (CU 32-085) in the treatment of Parkinson's disease.
Topics: Adult; Aged; Antiparkinson Agents; Drug Administration Schedule; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Time Factors | 1986 |
Efficacy of pergolide and mesulergine.
Topics: Aged; Antiparkinson Agents; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Ergolines; Humans; Levodopa; Middle Aged; Parkinson Disease; Pergolide | 1986 |
Initial treatment of parkinsonism with 8-alpha-amino-ergoline.
Topics: Adult; Aged; Ergolines; Female; Humans; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Psychomotor Performance | 1985 |
Three-year observation of mesulergine (CU 32-085) in advanced and newly treated parkinsonism.
Topics: Adult; Aged; Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1985 |